Effect of β(2)-adrenergic receptor polymorphism on response to longacting β(2) agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial

BACKGROUND: Combined long-acting β(2)-agonist and inhaled corticosteroid (LABA/ICS) therapy improves outcomes in many asthmatics. Some studies suggest that patients homozygous for arginine at the 16(th) amino-acid position of the β(2) adrenergic receptor (B16 Arg/Arg) benefit less than those with B1...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Główni autorzy: Wechsler, Michael E., Kunselman, Susan J., Chinchilli, Vernon M, Bleecker, Eugene, Boushey, Homer A., Calhoun, William J., Ameredes, Bill T., Castro, Mario, Craig, Timothy J, Denlinger, Loren, Fahy, John V., Jarjour, Nizar, Kazani, Shamsah, Kim, Sophia, Kraft, Monica, Lazarus, Stephen C., Lemanske, Robert F, Markezich, Amy, Martin, Richard J., Permaul, Perdita, Peters, Stephen P, Ramsdell, Joe, Sorkness, Christine A., Sutherland, E Rand, Szefler, Stanley J, Walter, Michael J, Wasserman, Stephen, Israel, Elliot
Format: Artigo
Język:Inglês
Wydane: 2009
Hasła przedmiotowe:
Article
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2914569/
https://ncbi.nlm.nih.gov/pubmed/19932356
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(09)61492-6
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy